Vanessa Fritz

Summary

Country: France

Publications

  1. ncbi Micro-CT combined with bioluminescence imaging: a dynamic approach to detect early tumor-bone interaction in a tumor osteolysis murine model
    Vanessa Fritz
    INSERM U844, CHU Saint Eloi, 80 rue Augustin Fliche, 34091 Montpellier Cedex 5, France
    Bone 40:1032-40. 2007
  2. ncbi Mesenchymal stem cells: an emerging tool for cancer targeting and therapy
    Vanessa Fritz
    INSERM U844, CHU Hôpital Saint Eloi Bâtiment INM, BP74103, 80 rue Augustin Fliche, 34091 Montpellier Cedex 5, France
    Curr Stem Cell Res Ther 3:32-42. 2008
  3. ncbi Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor
    Vanessa Fritz
    Institut National de la Santé et de la Recherche Médicale U844, Montpellier, France
    Stem Cells 26:2981-90. 2008
  4. ncbi Mesenchymal stem cells and rheumatoid arthritis
    Christian Jorgensen
    Immunorheumatology Department, Lapeyronie Hospital, 34295 Montpellier Cedex 5, France
    Joint Bone Spine 70:483-5. 2003
  5. ncbi Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer
    Jean Sebastien Annicotte
    Equipe Avenir, INSERM U540, 60 rue de Navacelles, F 34090 Montpellier, France
    Mol Cell Biol 26:7561-74. 2006
  6. ncbi Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis
    Farida Djouad
    INSERM U475, Montpellier, France
    Arthritis Rheum 52:1595-603. 2005

Collaborators

Detail Information

Publications6

  1. ncbi Micro-CT combined with bioluminescence imaging: a dynamic approach to detect early tumor-bone interaction in a tumor osteolysis murine model
    Vanessa Fritz
    INSERM U844, CHU Saint Eloi, 80 rue Augustin Fliche, 34091 Montpellier Cedex 5, France
    Bone 40:1032-40. 2007
    ..This model will help to assess new therapeutic approaches targeting intraosseous tumor growth or tumor/osteoclast crosstalk...
  2. ncbi Mesenchymal stem cells: an emerging tool for cancer targeting and therapy
    Vanessa Fritz
    INSERM U844, CHU Hôpital Saint Eloi Bâtiment INM, BP74103, 80 rue Augustin Fliche, 34091 Montpellier Cedex 5, France
    Curr Stem Cell Res Ther 3:32-42. 2008
    ..This review highlights recent works and potential clinical applications of MSCs in this field...
  3. ncbi Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor
    Vanessa Fritz
    Institut National de la Santé et de la Recherche Médicale U844, Montpellier, France
    Stem Cells 26:2981-90. 2008
    ..Disclosure of potential conflicts of interest is found at the end of this article...
  4. ncbi Mesenchymal stem cells and rheumatoid arthritis
    Christian Jorgensen
    Immunorheumatology Department, Lapeyronie Hospital, 34295 Montpellier Cedex 5, France
    Joint Bone Spine 70:483-5. 2003
  5. ncbi Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer
    Jean Sebastien Annicotte
    Equipe Avenir, INSERM U540, 60 rue de Navacelles, F 34090 Montpellier, France
    Mol Cell Biol 26:7561-74. 2006
    ..These results open up new therapeutic perspectives in the treatment of prostate cancer...
  6. ncbi Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis
    Farida Djouad
    INSERM U475, Montpellier, France
    Arthritis Rheum 52:1595-603. 2005
    ..CONCLUSION: Our data suggest that environmental parameters, in particular those related to inflammation, may influence the immunosuppressive properties of MSCs...